New York, NY – According to filings with the U.S. Securities and Exchange Commission, Capital Rx is raising $105,999,993.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, AJ Loiacono played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Capital Rx
Capital Rx is built around the mission of changing the way prescription drugs are priced and patients are serviced. A health technology company daring to reimagine the pharmacy benefits industry, Capital Rx is executing on that mission through its Clearinghouse Model – the first ethical framework for drug pricing. Capital Rxs enterprise pharmacy platform, JUDI, connects every aspect of the pharmacy ecosystem in one platform, enabling patient engagement, and increasing efficiency to achieve the highest standards of clinical care.

To learn more about Capital Rx, visit http://cap-rx.com/

Contact:
AJ Loiacono, Chief Executive Officer
(888) 617-6521
aj@cap-rx.com
https://www.linkedin.com/in/capitalrx/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved